share_log

中國生物製藥:董事會召開通知

SINO BIOPHARM: NOTIFICATION OF BOARD MEETING

香港交易所 ·  Mar 1 03:34
Summary by Moomoo AI
中國生物製藥有限公司宣佈,將於2024年3月28日(星期四)召開董事會會議。會議的主要目的是批准及公佈公司及其附屬公司截至2023年12月31日止年度的年度業績,並將考慮建議派發末期股息。此次會議由公司秘書陳凱年於2024年3月1日發出通知。目前,中國生物製藥的董事會由七位執行董事和五位獨立非執行董事組成。
中國生物製藥有限公司宣佈,將於2024年3月28日(星期四)召開董事會會議。會議的主要目的是批准及公佈公司及其附屬公司截至2023年12月31日止年度的年度業績,並將考慮建議派發末期股息。此次會議由公司秘書陳凱年於2024年3月1日發出通知。目前,中國生物製藥的董事會由七位執行董事和五位獨立非執行董事組成。
CHINA BIOPHARMACEUTICAL CO., LTD. ANNOUNCED THAT IT WILL HOLD A BOARD MEETING ON THURSDAY, MARCH 28, 2024. THE PRIMARY PURPOSE OF THE MEETING IS TO APPROVE AND ANNOUNCE THE ANNUAL RESULTS OF THE COMPANY AND ITS SUBSIDIARIES FOR THE YEAR ENDED 31 DECEMBER 2023, AND CONSIDERATION WILL BE GIVEN TO THE PROPOSED DISTRIBUTION OF A FINAL DIVIDEND. THE MEETING WAS NOTIFIED ON 1 MARCH 2024 BY THE COMPANY SECRETARY, CHAN KAI NIN. Currently, the Board of Directors of China Biopharmaceuticals consists of seven executive directors and five independent non-executive directors.
CHINA BIOPHARMACEUTICAL CO., LTD. ANNOUNCED THAT IT WILL HOLD A BOARD MEETING ON THURSDAY, MARCH 28, 2024. THE PRIMARY PURPOSE OF THE MEETING IS TO APPROVE AND ANNOUNCE THE ANNUAL RESULTS OF THE COMPANY AND ITS SUBSIDIARIES FOR THE YEAR ENDED 31 DECEMBER 2023, AND CONSIDERATION WILL BE GIVEN TO THE PROPOSED DISTRIBUTION OF A FINAL DIVIDEND. THE MEETING WAS NOTIFIED ON 1 MARCH 2024 BY THE COMPANY SECRETARY, CHAN KAI NIN. Currently, the Board of Directors of China Biopharmaceuticals consists of seven executive directors and five independent non-executive directors.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more